Medtronic Plc (MDT) has seen significant investment activity as of late, with a number of acquisitions and sell-offs by various institutions. Notably,
JB Capital LLC purchased 6,515 shares and
Aberdeen Group acquired 27,470 shares. Meanwhile, others such as
Venturi Wealth Management LLC and
US Bancorp DE have reduced their holdings. However, Medtronic continues to generate interest in the market with increased positions by
WestEnd Advisors LLC and
Godsey & Gibb Inc. In the midst of these investment movements, Medtronic continues its technological advances. The company initiated a U.S.
IDE clinical study evaluating its Hugo™ robotic-assisted surgery system for gynecological procedures. The
FDA also approved its SmartGuard Algorithm as an automated glycemic controller. Despite these advancements, the company's shares have experienced fluctuations, suffering drops while also showing resilience in the recent earnings report.
Medtronic Plc MDT News Analytics from Tue, 29 Jul 2025 07:00:00 GMT to Sat, 11 Oct 2025 11:43:26 GMT -
Rating -2
- Innovation 6
- Information 8
- Rumor -4
